Mitochondrial Drugs for Alzheimer Disease

Therapeutic strategies for Alzheimer disease (AD) have yet to offer a diseasemodifying effect to stop the debilitating progression of neurodegeneration and cognitive decline. Rather, treatments thus far are limited to agents that slow disease progression without halting it, and although much work to...

Full description

Bibliographic Details
Main Authors: Xiongwei Zhu, Mark A. Smith, Katarzyna A. Gustaw-Rothenberg, George Perry, Xinglong Wang, David J. Bonda
Format: Article
Language:English
Published: MDPI AG 2009-12-01
Series:Pharmaceuticals
Subjects:
Online Access:http://www.mdpi.com/1424-8247/2/3/287/